Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . October 24th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Cancer Symptom Distress - Thirteen "Core" Factors Account for Majority of Symptoms and Side Effects
Colorectal Cancer - New First-Line Chemotherapy Treatment Developed for Metastatic Disease
Testicular Cancer - High-Dose Chemotherapy Effective in Patients with Recurrent Disease
Cancer Therapies - Inhaled Isotretinoin Can Lower Risk of Lung and Aerodigestive Cancers While Minimizing Toxicity
Colorectal Cancer - Mutations in Newly Discovered Gene Result in Defective Mismatch Repair
Cutaneous Melanoma - Long-Term Trials Indicate that Smaller Resection Margins Don't Compromise Results
Prostate Cancer - Prognostic Tool Can Help Patients Make Treatment Decisions
Testicular Cancer - Link Made to Male Infertility
Actinic Keratoses - Therapy Receives FDA Approval to Treat Common Skin Lesions
Cancer Research - Oncologist: 2000 a Watershed Year
Leukemia - FDA Approves Arsenic Trioxide in Record Time for Cancer Drug Development Program
Melanoma - Biological License Application to be Filed for Stage II Melanoma Vaccine
Non-Hodgkin's Lymphoma - Phase III Clinical Trial Begins with Lymphoma Antibody
Oral Cancer - OraTest Clinical Study Moving Forward
Anti-Angiogenesis - New Drug Stops Growth of Human Tumors in Mice
Breast Cancer - Select Enzyme Receptors Correlate with Cancer Invasion, Not Progression
Cachexia - Study Appears to Show Why Muscle Decays Mysteriously in Cancer, AIDS, Other Illnesses
Cancer Gene Therapy - Scientists to Try Altering Gene Carrier to Improve its Ability to Bind to Cancer Cells
Cancer Therapies - Expert Calls for New Thinking on Clinical Trials and Drug Spending
Cancer Therapies - VEGF Receptor Agonist ZD6474 Causes Tumor Inhibition and Regression in Mice
Kidney Cancer - Combination Chemoimmunotherapy Regimen Results Are Mixed
Melanoma - New Direct Assay Evaluates Tumor Peptide Vaccine Response
Neuroblastoma - Interleukin-8 and Its Receptors May Promote Angiogenesis
Ovarian Cancer - Clinical Trials Planned for First-Line Interferon Therapy
Pancreatic Cancer - Sm-Like Oncogene is Novel Target for Gene Therapy
Prostate Cancer - p53 Adenovirus-Mediated Transfer Suppresses Primary Tumor Growth and Metastasis
Prostate Cancer - Macrophages Important to Tumor Pathology but Don't Predict Future
Prostate Cancer - Therapeutic Vaccine Selected for Human Testing
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
